ARCHIVES

Two OAM Advisors Criticize Third over ACS Membership

This article is from The Cancer Letter archive.

Vol. 19 No. 30 | July 23, 1993

Download PDF Visit The Full Archive

Related Articles

First Panel Meeting On Centers Generates Possible Recommendations For Core Grant Guideline Changes

April 6, 1984

In Brief: Cavenee Is President-elect of AACR; Coffey To Succeed Strong As President

April 11, 1997

NTP Staff Members In Bethesda Told They Must Move

December 16, 1983

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling

March 12, 1999